iifl-logo

Goldline Pharmaceutical Ltd Share Price Live

Add as a Preferred Source on Google
46.14
(4.98%)
May 27, 2026|05:30:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

Equities

Futures

Option

No Chart Data Available

  • Open41.76
  • Day's High46.14
  • 52 Wk High60
  • Prev. Close43.95
  • Day's Low41.76
  • 52 Wk Low 41.76
  • Turnover (lac)167.48
  • P/E0
  • Face Value10
  • Book Value20.99
  • EPS0
  • Mkt. Cap (Cr.)44.29
  • Div. Yield0
View All Historical Data

No Record Found

No Record Found

Goldline Pharmaceutical Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

₹41.76

Prev. Close

₹43.95

Turnover(Lac.)

₹167.48

Day's High

₹46.14

Day's Low

₹41.76

52 Week's High

₹60

52 Week's Low

₹41.76

Book Value

₹20.99

Face Value

₹10

Mkt Cap (₹ Cr.)

44.29

P/E

0

EPS

0

Divi. Yield

0

Goldline Pharmaceutical Ltd Corporate Action

No Record Found

Goldline Pharmaceutical Ltd NEWS AND UPDATE

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

Goldline Pharmaceutical Ltd SHAREHOLDING SNAPSHOT

28 May, 2026|11:31 PM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 79.70%

Foreign: 0.00%

Indian: 79.70%

Non-Promoter- 20.29%

Institutions: 20.29%

Non-Institutions: 0.00%

Custodian: 0.00%

Share PriceShare Price

Goldline Pharmaceutical Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Y/e 31 Mar( In .Cr)Mar-2025Mar-2024Mar-2023

Equity Capital

6.9

2.3

2

Preference Capital

1.81

1.81

1.81

Reserves

1.65

3.76

2.08

Net Worth

10.36

7.87

5.89

Minority Interest

View Balance Sheet

No Record Found

No Record Found

No Record Found

No Record Found

Goldline Pharmaceutical Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceutical Industries Ltd

SUNPHARMA

1,845

147.484,42,677.3608.70.874,887.2793.23

Divis Laboratories Ltd

DIVISLAB

6,797.7

67.781,80,457.587560.442,793629.49

Torrent Pharmaceuticals Ltd

TORNTPHARM

4,540.9

68.471,53,684.6946702,677249.73

Cipla Ltd

CIPLA

1,418.2

30.961,14,562.27384.640.923,840.92423.38

Dr Reddys Laboratories Ltd

DRREDDY

1,319.05

34.191,10,095.43-219.40.613,802.6375.78

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Goldline Pharmaceutical Ltd

Management

Register Office

Registrar Office

Chairman / Executive Director / M D / Promoter

AMOL LAXMIKANT MUJUMDAR

WTD & Executive Director

Swapan Prernprakash Khandelwal

Executive Director

Prashant Shriknshna Karkare

Executive Director

Avinash Pandurang Ambulkar

Non Executive Director

Prashant Vithal Rahate

Independent Non Exe. Director

Mehul Hari Ranade

Independent Non Exe. Director

Renuka Saurabh Borole

Independent Non Exe. Director

Shraddha Kiran Kulkarni

Company Sec. & Compli. Officer

Ruchi Sanket Modi

Registered Office

103 F-1 Leela Apartment Shilpa,

HSG Society Shanidham Narendra,

Maharashtra - 440015

Tel: +91 712 278 6666

Website: http://www.goldlinepharma.in

Email: info@goldlinepharma.in

Registrar Office

Office No S6-2,

Pinnacle Busine.Park, Mahakali Caves Road,

Mumbai - 400093

Tel: 91-22-62638200

Website: www.bigshareonline.com

Email: investor@bigshareonline.com / info@bigshareonline.com

Summary

Goldline Pharmaceutical Limited was originally incorporated on August 2, 2004, as a private limited Company in the name of Goldline Pharmaceutical Private Limited with the Registrar of Companies, Mumb...
Read More

Company FAQs

What is the Goldline Pharmaceutical Ltd share price today?

The Goldline Pharmaceutical Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is ₹46.14 today.

What is the Market Cap of Goldline Pharmaceutical Ltd?

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Goldline Pharmaceutical Ltd is ₹44.29 Cr. as of 27 May ‘26

What is the PE and PB ratio of Goldline Pharmaceutical Ltd?

The PE and PB ratios of Goldline Pharmaceutical Ltd is 0 and 2.20 as of 27 May ‘26

What is the 52 Week High and Low of Goldline Pharmaceutical Ltd?

The 52-week high/low is the highest and lowest price at which a Goldline Pharmaceutical Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Goldline Pharmaceutical Ltd is ₹41.76 and ₹60 as of 27 May ‘26

What is the CAGR of Goldline Pharmaceutical Ltd?

Goldline Pharmaceutical Ltd's CAGR for 5 Years at N/I%, 3 Years at N/I%, 1 Year at N/I%, 6 Month at N/I%, 3 Month at N/I% and 1 Month at -18.72%.

What is the shareholding pattern of Goldline Pharmaceutical Ltd?

The shareholding pattern of Goldline Pharmaceutical Ltd is as follows:
Promoters - 57.29 %
Institutions - 12.97 %
Public - 29.74 %
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.